Literature DB >> 21681110

Critical role for P-glycoprotein expression in hematopoietic cells in the FVB.Mdr1a(-/-) model of colitis.

Elizabeth M Staley1, Reed A Dimmitt, Trenton R Schoeb, Scott M Tanner, Robin G Lorenz.   

Abstract

OBJECTIVE: P-glycoprotein (P-gp), the functional product of the multidrug resistance gene (MDR), is a transmembrane protein that extrudes substrates from the intracellular environment. P-gp is expressed on the apical surface of epithelial cells and on cells from the hematopoietic lineage. Human MDR polymorphisms have been associated with the increased risk of inflammatory bowel disease, and FVB/N animals deficient in mdr1a expression develop spontaneous colitis. Previous studies using adult bone marrow chimeras indicated that colitis development in this animal model was contingent on P-gp deficiency in radiation-resistant epithelial cells; however, the use of adult animals may mask the role of hematopoietic immune cells in colitis initiation, due to preexisting epithelial abnormalities. SUBJECTS AND METHODS: To assess the importance of P-gp expression in intestinal epithelial and hematopoietic-derived cells on colitis induction in FVB.mdr1a(-/-) animals, we developed a neonatal model of bone marrow reconstitution. FVB/N and FVB.mdr1a(-/-) adult and neonatal animals were lethally irradiated and reconstituted with bone marrow from FVB/N or FVB.mdr1a(-/-) donors. Animals were observed for 20 weeks.
RESULTS: Adult FVB/N animals deficient in P-gp expression in hematopoietically derived immune cells developed colitis similar to adult animals deficient in P-gp expression in radiation-resistant epithelial/stromal cells. Neonatal animals deficient in P-gp expression in hematopoietically derived immune cells developed a more histologically significant colitis than those deficient in P-gp expression in epithelial tissue.
CONCLUSIONS: The use of a neonatal model of bone marrow reconstitution has revealed a critical role for P-gp expression in hematopoietically derived immune cells in colitis development in the FVB.mdr1a(-/-) model.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21681110      PMCID: PMC3658612          DOI: 10.1097/MPG.0b013e31822860f1

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  27 in total

Review 1.  P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.

Authors:  M F Fromm
Journal:  Int J Clin Pharmacol Ther       Date:  2000-02       Impact factor: 1.366

2.  Inflammatory bowel disease is associated with changes of enterocytic junctions.

Authors:  N Gassler; C Rohr; A Schneider; J Kartenbeck; A Bach; N Obermüller; H F Otto; F Autschbach
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-07       Impact factor: 4.052

3.  Epithelial dysfunction associated with the development of colitis in conventionally housed mdr1a-/- mice.

Authors:  Silvia Resta-Lenert; Jane Smitham; Kim E Barrett
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-03-17       Impact factor: 4.052

4.  P-glycoprotein (encoded by multidrug resistance genes) is not required for interleukin-2 secretion in mice and humans.

Authors:  S Gollapudi; C Kim; S Gupta
Journal:  Genes Immun       Date:  2000-08       Impact factor: 2.676

5.  P-glycoprotein functions as a differentiation switch in antigen presenting cell maturation.

Authors:  S S Pendse; S Behjati; T Schatton; A Izawa; M H Sayegh; M H Frank
Journal:  Am J Transplant       Date:  2006-12       Impact factor: 8.086

Review 6.  Genuine functions of P-glycoprotein (ABCB1).

Authors:  Takaharu Mizutani; Masatoshi Masuda; Emi Nakai; Kenji Furumiya; Hiroshi Togawa; Yutaka Nakamura; Yuko Kawai; Keiko Nakahira; Shigeko Shinkai; Kazuhiko Takahashi
Journal:  Curr Drug Metab       Date:  2008-02       Impact factor: 3.731

7.  Early molecular and functional changes in colonic epithelium that precede increased gut permeability during colitis development in mdr1a(-/-) mice.

Authors:  Andrew Collett; Norman B Higgs; Meritxell Gironella; Leo A H Zeef; Andy Hayes; Emil Salmo; Najib Haboubi; Juan L Iovanna; Gordon L Carlson; Geoffrey Warhurst
Journal:  Inflamm Bowel Dis       Date:  2008-05       Impact factor: 5.325

8.  Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn's disease.

Authors:  T Fiedler; C Büning; W Reuter; G Pitre; E Gentz; H H Schmidt; J Büttner; J Ockenga; T Gerloff; C Meisel; H Lochs; I Roots; K Köpke; A Johne
Journal:  Eur J Clin Pharmacol       Date:  2007-07-31       Impact factor: 2.953

9.  Differential susceptibility of P-glycoprotein deficient mice to colitis induction by environmental insults.

Authors:  Elizabeth M Staley; Trenton R Schoeb; Robin G Lorenz
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

Review 10.  P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype.

Authors:  Monica Pallis; Julie Turzanski; Yutaro Higashi; Nigel Russell
Journal:  Leuk Lymphoma       Date:  2002-06
View more
  7 in total

1.  Altered generation of induced regulatory T cells in the FVB.mdr1a-/- mouse model of colitis.

Authors:  S M Tanner; E M Staley; R G Lorenz
Journal:  Mucosal Immunol       Date:  2012-08-08       Impact factor: 7.313

2.  TLR signaling modulates side effects of anticancer therapy in the small intestine.

Authors:  Magdalena Frank; Eva Maria Hennenberg; Annette Eyking; Michael Rünzi; Guido Gerken; Paul Scott; Julian Parkhill; Alan W Walker; Elke Cario
Journal:  J Immunol       Date:  2015-01-14       Impact factor: 5.422

3.  Maintenance of host leukocytes in peripheral immune compartments following lethal irradiation and bone marrow reconstitution: implications for graft versus host disease.

Authors:  Elizabeth M Staley; Scott M Tanner; Joseph G Daft; Andrea L Stanus; Steven M Martin; Robin G Lorenz
Journal:  Transpl Immunol       Date:  2013-01-17       Impact factor: 1.708

4.  Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.

Authors:  Vibeke Andersen; Katrine Svenningsen; Lina Almind Knudsen; Axel Kornerup Hansen; Uffe Holmskov; Allan Stensballe; Ulla Vogel
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 5.  Animal models of ulcerative colitis and their application in drug research.

Authors:  Daren Low; Deanna D Nguyen; Emiko Mizoguchi
Journal:  Drug Des Devel Ther       Date:  2013-11-12       Impact factor: 4.162

6.  High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence.

Authors:  Vibeke Andersen; Lotte K Vogel; Tine Iskov Kopp; Mona Sæbø; Annika W Nonboe; Julian Hamfjord; Elin H Kure; Ulla Vogel
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

7.  P-glycoprotein multidrug transporter in inflammatory bowel diseases: More questions than answers.

Authors:  Elke Cario
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.